{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T04:24:36Z","timestamp":1772252676029,"version":"3.50.1"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jchromb.2023.123723","type":"journal-article","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T07:11:28Z","timestamp":1681974688000},"page":"123723","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Development and validation of LC\u2013MS\/MS methods for the determination of EVT201 and its five metabolites in human urine: Application to a mass balance study"],"prefix":"10.1016","volume":"1223","author":[{"given":"Man","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunmiao","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huichen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jchromb.2023.123723_b0005","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jsmc.2019.10.002","article-title":"Insomnia and cognitive performance","volume":"15","author":"Brownlow","year":"2020","journal-title":"Sleep. Med. Clin."},{"key":"10.1016\/j.jchromb.2023.123723_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1179573518770672","article-title":"Pharmacotherapy of insomnia","volume":"10","author":"Neubauer","year":"2018","journal-title":"J. Cent. Nerv. Syst. Dis."},{"issue":"3","key":"10.1016\/j.jchromb.2023.123723_b0015","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1517\/13543784.2015.987340","article-title":"Current phase II investigational therapies for insomnia","volume":"24","author":"Zisapel","year":"2015","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.jchromb.2023.123723_b0020","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.pharmthera.2005.04.014","article-title":"Treating insomnia: Current and investigational pharmacological approaches","volume":"112","author":"Ebert","year":"2006","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.jchromb.2023.123723_b0025","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0166-2236(96)80023-3","article-title":"Which GABAA-receptor subtypes really occur in the brain?","volume":"19","author":"McKernan","year":"1996","journal-title":"Trends Neurosci."},{"issue":"5","key":"10.1016\/j.jchromb.2023.123723_b0030","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0197-0186(99)00045-5","article-title":"Structure and subunit composition of GABAA receptors","volume":"34","author":"Sieghart","year":"1999","journal-title":"Neurochem. Int."},{"issue":"6","key":"10.1016\/j.jchromb.2023.123723_b0035","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/75761","article-title":"Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor \u03b11 subtype","volume":"3","author":"McKernan","year":"2000","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.jchromb.2023.123723_b0040","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.300.1.2","article-title":"A new benzodiazepine pharmacology","volume":"300","author":"M\u00f6hler","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jchromb.2023.123723_b0045","doi-asserted-by":"crossref","unstructured":"W.B. Mendelson, T. Roth, J. Cassella, T. Roehrs, J.K. Walsh, J.H. Woods, D.J. Buysse, R.E. Meyer, The treatment of chronic insomnia: drug indications, chronic use and abuse liability. Summary of a 2001 new clinical drug evaluation unit meeting symposium, Sleep Med. Rev. 8 (1) (2004) 7-17.","DOI":"10.1016\/S1087-0792(03)00042-X"},{"key":"10.1016\/j.jchromb.2023.123723_b0050","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S1389-9457(04)90002-0","article-title":"The benzodiazepine site of the GABAA receptor: an old target with new potential?","volume":"1","author":"Bateson","year":"2004","journal-title":"Sleep Med. Suppl."},{"issue":"1","key":"10.1016\/j.jchromb.2023.123723_b0055","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jsmc.2014.11.002","article-title":"Non-benzodiazepine receptor agonists for insomnia","volume":"10","author":"Becker","year":"2015","journal-title":"Sleep Med. Clin."},{"issue":"1","key":"10.1016\/j.jchromb.2023.123723_b0060","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.sleep.2009.07.012","article-title":"Treatment of elderly primary insomnia patients with EVT 201 improves sleep initiation, sleep maintenance, and daytime sleepiness","volume":"11","author":"Walsh","year":"2010","journal-title":"Sleep. Med."},{"key":"10.1016\/j.jchromb.2023.123723_b0065","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jpba.2018.06.001","article-title":"Simultaneous quantification of EVT201, a novel partial positive allosteric GABAA receptor modulator, and its two metabolites in human plasma by UHPLC\/MS\/MS","volume":"159","author":"Zhang","year":"2018","journal-title":"J. Pharm. Biomed. Anal."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023223001332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023223001332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:10:25Z","timestamp":1761606625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023223001332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":13,"alternative-id":["S1570023223001332"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2023.123723","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of LC\u2013MS\/MS methods for the determination of EVT201 and its five metabolites in human urine: Application to a mass balance study","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2023.123723","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"123723"}}